Physician profile
Leslie Sciumbato
NPI 1790941185
$1,842.49
in general payments reported to CMS, 2019-2025
20 companies · $430 in 2025
The $430 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $96.99 · 2021: $50.93 · 2022: $190 · 2023: $80.83 · 2024: $371 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $881.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $372.58 | 2019-2025 | Precision 1, Eysuvis |
| Tarsus Pharmaceuticals, INC. | $270.32 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $208.45 | 2024 | Miebo, Xiidra |
| Johnson & Johnson Vision Care, INC. | $153.43 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $129.91 | 2019-2024 | |
| Glaukos Corporation | $106.48 | 2019 | |
| Optos, INC. | $89.63 | 2019 | |
| Abbvie INC. | $86.10 | 2022-2023 | Vuity, Alphagan P, Lumigan |
| Biotissue Holdings INC. | $78.20 | 2019 | |
| Ivantis, INC | $77.59 | 2020 | |
| Novartis Pharmaceuticals Corporation | $64.77 | 2022-2023 | |
| Coopervision INC. | $58.99 | 2019 | |
| Maculogix, INC. | $27.08 | 2019 | |
| Eyevance Pharmaceuticals LLC | $24.73 | 2019 | |
| Shire North American Group INC | $21.27 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Rxsight INC | $15.64 | 2022 | |
| Kala Pharmaceuticals, INC. | $13.19 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.94 | 2019 | |
| Allergan, INC. | $11.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Sciumbato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.